In addition to morphological studies, cytochemical and immunological studies are now performed routinely on bone marrow aspirate samples obtained from patients with leukaemia or lymphoma. Similar studies, if performed on bone marrow biopsy specimens, could be far more informative because tissue organisation would be maintained in histological preparations, and sampling errors inherent in the bone marrow aspiration technique avoided. Unfortunately, however, the combination of an improved histological embedding technique for semithin sectioning of undecalcified bone in methylmethacrylate (MMA) with special enzyme or immunohistochemistry methods, has been unsuccessful to date. The shortcomings have been attributed to the MMA embedding medium.' They can, however, be overcome by dividing the cylindrical marrow core in half, longitudinally, and then processing one half into methyl-methacrylate for optimal morphology23 and the other half into glycolmethacrylate (GMA) for enzyme or immunohistology.45 Water miscibility and low temperature processing make GMA a suitable embedding medium, and in this way the adjacent areas of optimally processed marrow cores can be examined by useful and complimentary techniques. This paper describes the invention of a simple instrument (fig 1) that longitudinally hemisections cylindrical biopsy specimens of cancellous bone and reconciles the recent technological improvements that are necessary for optimal morphological, histochemical, and immunohistological analysis of bone marrow biopsy specimens.
Material and methods

INSTRUMENT
The instrument has four basic parts: (i) the circular saw (0-1 mm thick and 80 mm in diameter), mounted on (ii) an electrically operated drill; (iii) a brass recepAccepted for publication 15 July 1986 tacle with a small brass top to hold the biopsy specimen in place while it is being split; and (iv) an on/off switch. The brass receptacle has a centre groove with a 0-3 mm slit for the saw to pass through and has been specially designed for bone marrow The brass receptacle has been designed so that immediately after the biopsy needle is withdrawn from the patient, the biopsy sample can be pushed directly into the receptacle's biopsy receiving groove. When the biopsy is in place, the small brass top is placed over the biopsy specimen to hold it in place. The marrow biopsy is then divided in half longitudinally by the electrically operated circular saw, as the brass receptacle glides forward over an aluminium platform. The speed of the saw is regulated to prevent frictional damage or burning of the tissue. When the biopsy is divided,.the portions are removed, appropriately fixed and dehydrated, and processed separately into MMA and GMA. The cut surfaces of the biopsy sample are placed downward during embedding so that the maximum width of the specimen is available for sectioning and examination.
Results
The instrument has been tested on a large number of bone marrow biopsy samples obtained from patients with various haematological malignancies. In each case the specimens were adequately divided longitudinally into two equal halves, with no damage or distortion to the marrow tissue. Morphological and structural preservation of the marrow was good (fig 2b) , and the results for immunostaining methods were excellent (fig 3) .
Discussion
Bone marrow biopsy specimens are now used routinely to investigate and diagnose various haematological and non-haematological malignant conditions.7 - 9 The conventional method of decalcification and paraffin embedding, however, produces shrinkage, considerable loss of cellular details, and reduces the quality of staining of haemopoietic tissue. Thus cells from the haematopoietic system are more difficult to identify in the sections of paraffin embedded tissue. The shortcomings were attributed to the MMA embedding medium. The adaptation of plastic embedding to undecalcified marrow cores provides excellent preservation of the marrow architecture and cellular detail, but, even in such an improved histological section preparation, it is sometimes difficult to identify precisely the nature of disease in the marrow, and enzyme or immunohistological studies become essential to characterise the type of cells or sanctuary of cells participating in the malignant process. These can be done by processing one half of the biopsy specimen in MMA and by snap freezing the other half, and then sectioning it in a cryostat, as has been advocated by Bartle et al.' This technique, however, has its own inherent disadvantages,17 all of which can now be overcome by embedding tissues in glycolmethacrylate (detailed methods of GMA embedding technique for enzyme and immunohistochemistry will be published elsewhere).
The instrument described here offers a possibility of combining optimal morphological studies with enzyme and immunohistological studies to be done simultaneously on one biopsy specimen. In this way valuable information can be obtained which would otherwise not be noticed-for example, in a recent case of non-Hodgkin's lymphoma a bone marrow biopsy specimen processed in paraffin showed dense marrow infiltration by mononuclear lymphoid cells (fig 2a) . Diffuse well differentiated lymphocytic lymphoma was diagnosed. Plasma cells were reported to be present, but not increased noticeably. The one half of the bone marroW biopsy specimen processed in MMA, however, clearly showed marrow infiltration by a large number (30%-50%) of plasma cells (fig 2b) , in addition to the mature looking mononuclear lymphocytes. Immunological studies on the other half of the same bone marrow biopsy specimen processed in GMA clearly showed the presence of IgA and K immunoglobulin (fig 3) in those plasma cells, indicating the clonal nature of plasma cell proliferation.
Bone marrow disease with lymphoma and other malignancies may be focal, and the presence of lymphoid nodules in otherwise normal marrow may make it difficult to identify it as normal. In such cases longitudinal hemisectioning of long core biopsy specimens and then processing the bone marrow biopsy halves in MMA and GMA for optimal morphology and immunohistology would have an important role in identifying and characterising a malignant process entailing the bone marrow. 
London
The increasing requirements of immunosuppressed patients for blood and blood components from donors uninfected with cytomegalovirus (CMV) led us to search for a sensitive, rapid, convenient and economical test for screening blood donations for antibodies against this virus.
Initially, we used a modification of a commercial haemagglutination (HA) assay (Cetus Corporation, Berkeley, California); this entailed 10-fold dilution of the red cells provided in the kit and assessment of agglutination in a microplate inclined at 700 after centrifugation at 387g for one minute.' Although this test proved suitable for the selection of plasma with high titre anti-CMV for the manufacture of specific immunoglobulin, its sensitivity and specificity was unacceptably variable for selecting CMV free donations. This became apparent when 23% (28 of 124) donations found negative for anti-CMV by modified HA were found to be positive for CMV antibodies by radioimmunoassay. We therefore decided to use a modified latex agglutination as our routine screening test (CMV Scan, Becton and Dickinson, Baltimore, Maryland). We tested this assay in parallel with the modified HA test (MHA) using a sensitive radioimmunoassay described by Berry et al2 as a standard for comparison.
Accepted for publication 15 July 1986 Methods For the latex agglutination test 25 pl of test serum was pipetted on to black reaction cards and 15 p1 of latex coated with CMV antigen was added and mixed, according to the manufacturer's recommendations. Positive and negative control sera were also tested. The card was placed on a humidified rotator for eight minutes and then read. Samples positive for anti-CMV showed clear agglutination, whereas negative ones remained cloudy. The test was made more economical by diluting two volumes of the antigen coated latex with one volume of the titration buffer provided with the kit. Furthermore, the volumes of reagents were reduced to 15 p1 of test serum and 5 I of diluted latex. Even with these reduced volumes, the reactions could be read easily. Results Before using the modified latex test for screening donor sera, we confirmed that the reduced volume modifications, with or without dilution of the latex, provided the same end point titres as the standard method when either sera or plasma with high titre or low titre anti-CMV were assessed. When 252 donor serum samples found to give negative CMV antibody results by modified haemagglutination screen tests were rescreened under routine testing conditions by the reduced volume latex agglutination test (method A), 58 (23%) were found to be positive by the second test. These 58 samples were then retested by various methods (table 1) . A small number scored differently on this repeat testing. Table 2 gives detailed results for nine negative or "discrepant" sera at repeat testing. Furthermore, when 50 serum samples from donors found to be negative for anti-CMV by modified haemagglutination and by the two latex test modifications, were tested by monoclonal radioimmunoassay, 48 were clearly negative, and two samples showed only traces of antibody to CMV. The figure shows the
